What Does MAGA Really Mean?

Dr. Robert Malone Says He Can’t Support Trump While ex-President Stands By COVID-19 Jabs

https://www.newswars.com/dr-robert-malone-says-he-cant-support-trump-while-ex-president-stands-by-covid-19-jabs/

Dr. Robert Malone, the inventor of the mRNA technology in the COVID vaccines, said he can’t support former President Donald Trump as long as he continues defending the experimental shot.

During an interview with Real America’s Voice last week, Trump was asked if he’d acknowledge that the mRNA COVID shots are not as safe or effective as the public was told by the medical establishment.

But Trump doubled down, saying, “I was able to get something approved that, you know, that has proven to have saved a lot of lives. Some people say that I saved 100 million lives worldwide.”

“You have to understand, there are the pros and cons,” the president went on. “Some reports [say] that it’s the greatest thing that’s ever happened and we saved tens of millions of lives. Then you’ll read other reports [that] say there were some problems with the vaccine …but relatively small numbers.

“But, you know, you have many reports that say the vaccines save tens of millions of lives,” Trump reiterated. “That without the vaccines you would have had a thing … where perhaps 100 million people died.”

Malone was not impressed with Trump’s explanation, endorsing a statement that “this will not get him elected. I am out.”

Malone went on to say that he put together a film segment for Trump spelling out the dangers of the mRNA jab, to no avail.

“I shot a film segment designed to help DJT see the truth. No impact. As I said, it is with regret that I have to agree with Brian. This is different from Mikki’s point. This is DJT’s decision. I disagree,” he tweeted Friday.

Despite Trump’s repeated assurances, VAERS data and many other international peer-reviewed studies and reports are showing the COVID shot has major safety and efficacy issues.

Trump’s vaccine-pimping rhetoric proves BOTH parties are prostitutes to pharma and the central banks